These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1920959)

  • 1. Thyrotropin releasing hormone (TRH)-induced release of 7B2 (neuroendocrine polypeptide) in vivo and in vitro using adenoma cells of a patient with acromegaly.
    Natori S; Iguchi H; Ohashi M; Kitamoto T; Chrétien M; Nawata H
    Jpn J Med; 1991; 30(3):208-12. PubMed ID: 1920959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the release of a novel pituitary polypeptide (7B2) from the growth hormone-producing pituitary adenoma of patients with acromegaly.
    Natori S; Iguchi H; Nawata H; Kato K; Ibayashi H; Nakagaki H; Chrétien M
    J Clin Endocrinol Metab; 1988 Feb; 66(2):430-7. PubMed ID: 3123513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of octapeptide somatostatin analogue (SMS 201-995) on plasma 7B2 (a neuroendocrine polypeptide) levels in patients with acromegaly.
    Natori S; Iguchi H; Ohashi M; Nakao R; Bloom SR; Nawata H
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):49-55. PubMed ID: 2331811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of LHRH on plasma 7B2 in patients with gonadotropin-producing pituitary adenomas.
    Iguchi H; Demura R; Yasuda D; Wakasugi H
    Horm Metab Res; 1992 Jan; 24(1):31-3. PubMed ID: 1612556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
    Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
    Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3.
    Propato-Mussafiri R; Kanse SM; Ghatei MA; Bloom SR
    J Endocrinol; 1992 Jan; 132(1):107-13. PubMed ID: 1310712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
    Hulting AL; Wersäll J; Werner S
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory mechanisms of growth hormone (GH)-releasing peptide-, GH-releasing hormone-, and thyrotropin-releasing hormone-induced GH release in patients with acromegaly.
    Hanew K; Utsumi A; Tanaka A; Ikeda H; Yokogoshi Y
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3578-83. PubMed ID: 9768668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the serum hormone levels and histological findings in pituitary adenomas.
    Irsy G; Góth M; Bálint K; Slowik F; Szabolcs I; Pásztor E; Szilágyi G
    Exp Clin Endocrinol; 1986 Dec; 88(2):224-36. PubMed ID: 3104069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific release of a novel pituitary polypeptide, 7B2, from rat anterior pituitary cells in vitro by luteinizing hormone-releasing hormone.
    Deng JY; Chan JS; Seidah NG; Chrétien M
    Neuroendocrinology; 1986; 44(3):373-7. PubMed ID: 3100976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
    Renner U; Brockmeier S; Strasburger CJ; Lange M; Schopohl J; Müller OA; von Werder K; Stalla GK
    J Clin Endocrinol Metab; 1994 May; 78(5):1090-6. PubMed ID: 8175966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors determining the long-term outcome of surgery for acromegaly.
    Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
    QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H; Tamura T; Sasaki S; Takebe K
    Neuropeptides; 1993 Dec; 25(6):363-75. PubMed ID: 8127416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
    Watanobe H; Tamura T
    Neuropeptides; 1995 Feb; 28(2):115-24. PubMed ID: 7746355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.